(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine

C103H118Cl2F3N27O2 — CID 158299598

IUPAC(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine
SMILESCCC1(C)CCN(c2cnc3c(-c4ccc(OC(F)F)cc4)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cccc5c4ccn5C)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cn(C)c5ccccc45)[nH]nc3n2)CC1.CC[C@@H]1CCN(c2cnc3c(-c4ccccc4Cl)[nH]nc3n2)C[C@H]1O.C[C@@H]1CCCC12CCN(c1cnc3c(-c4cccc(Cl)c4F)[nH]nc3n1)CC2
InChIInChI=1S/2C22H26N6.C21H23ClFN5.C20H23F2N5O.C18H20ClN5O/c1-4-22(2)9-12-28(13-10-22)18-14-23-20-19(25-26-21(20)24-18)16-6-5-7-17-15(16)8-11-27(17)3;1-4-22(2)9-11-28(12-10-22)18-13-23-20-19(25-26-21(20)24-18)16-14-27(3)17-8-6-5-7-15(16)17;1-13-4-3-7-21(13)8-10-28(11-9-21)16-12-24-19-18(26-27-20(19)25-16)14-5-2-6-15(22)17(14)23;1-3-20(2)8-10-27(11-9-20)15-12-23-17-16(25-26-18(17)24-15)13-4-6-14(7-5-13)28-19(21)22;1-2-11-7-8-24(10-14(11)25)15-9-20-17-16(22-23-18(17)21-15)12-5-3-4-6-13(12)19/h5-8,11,14H,4,9-10,12-13H2,1-3H3,(H,24,25,26);5-8,13-14H,4,9-12H2,1-3H3,(H,24,25,26);2,5-6,12-13H,3-4,7-11H2,1H3,(H,25,26,27);4-7,12,19H,3,8-11H2,1-2H3,(H,24,25,26);3-6,9,11,14,25H,2,7-8,10H2,1H3,(H,21,22,23)/t;;13-;;11-,14-/m..1.1/s1
InChIKeyGMIKWALXLNIEBS-VZZMYGPZSA-N
MW1894.16 g/mol
LogP22.18
Rot. Bonds16

About (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine

(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine (PubChem CID 158299598) has the molecular formula C103H118Cl2F3N27O2 and a molecular weight of 1894.16 g/mol. Its IUPAC name is (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine.

Molecular Properties

Compound Name(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine
PubChem CID158299598
Molecular FormulaC103H118Cl2F3N27O2
Molecular Weight1894.16 g/mol
Exact Mass1891.93
IUPAC Name(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine
SMILESCCC1(C)CCN(c2cnc3c(-c4ccc(OC(F)F)cc4)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cccc5c4ccn5C)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cn(C)c5ccccc45)[nH]nc3n2)CC1.CC[C@@H]1CCN(c2cnc3c(-c4ccccc4Cl)[nH]nc3n2)C[C@H]1O.C[C@@H]1CCCC12CCN(c1cnc3c(-c4cccc(Cl)c4F)[nH]nc3n1)CC2
InChIInChI=1S/2C22H26N6.C21H23ClFN5.C20H23F2N5O.C18H20ClN5O/c1-4-22(2)9-12-28(13-10-22)18-14-23-20-19(25-26-21(20)24-18)16-6-5-7-17-15(16)8-11-27(17)3;1-4-22(2)9-11-28(12-10-22)18-13-23-20-19(25-26-21(20)24-18)16-14-27(3)17-8-6-5-7-15(16)17;1-13-4-3-7-21(13)8-10-28(11-9-21)16-12-24-19-18(26-27-20(19)25-16)14-5-2-6-15(22)17(14)23;1-3-20(2)8-10-27(11-9-20)15-12-23-17-16(25-26-18(17)24-15)13-4-6-14(7-5-13)28-19(21)22;1-2-11-7-8-24(10-14(11)25)15-9-20-17-16(22-23-18(17)21-15)12-5-3-4-6-13(12)19/h5-8,11,14H,4,9-10,12-13H2,1-3H3,(H,24,25,26);5-8,13-14H,4,9-12H2,1-3H3,(H,24,25,26);2,5-6,12-13H,3-4,7-11H2,1H3,(H,25,26,27);4-7,12,19H,3,8-11H2,1-2H3,(H,24,25,26);3-6,9,11,14,25H,2,7-8,10H2,1H3,(H,21,22,23)/t;;13-;;11-,14-/m..1.1/s1
InChIKeyGMIKWALXLNIEBS-VZZMYGPZSA-N
XLogP22.18
TPSA327.82 Ų
H-Bond Donors6
H-Bond Acceptors24
Rotatable Bonds16
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001894.16
LogP ≤ 522.18
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'dyes5A(27)', 'substructure': 'N/A'}

Analyze (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine?
The IUPAC name of (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine (CID 158299598) is (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine.
What is the SMILES notation for (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine?
The canonical SMILES for (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine is CCC1(C)CCN(c2cnc3c(-c4ccc(OC(F)F)cc4)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cccc5c4ccn5C)[nH]nc3n2)CC1.CCC1(C)CCN(c2cnc3c(-c4cn(C)c5ccccc45)[nH]nc3n2)CC1.CC[C@@H]1CCN(c2cnc3c(-c4ccccc4Cl)[nH]nc3n2)C[C@H]1O.C[C@@H]1CCCC12CCN(c1cnc3c(-c4cccc(Cl)c4F)[nH]nc3n1)CC2.
What is the InChIKey of (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine?
The InChIKey is GMIKWALXLNIEBS-VZZMYGPZSA-N. The full InChI is InChI=1S/2C22H26N6.C21H23ClFN5.C20H23F2N5O.C18H20ClN5O/c1-4-22(2)9-12-28(13-10-22)18-14-23-20-19(25-26-21(20)24-18)16-6-5-7-17-15(16)8-11-27(17)3;1-4-22(2)9-11-28(12-10-22)18-13-23-20-19(25-26-21(20)24-18)16-14-27(3)17-8-6-5-7-15(16)17;1-13-4-3-7-21(13)8-10-28(11-9-21)16-12-24-19-18(26-27-20(19)25-16)14-5-2-6-15(22)17(14)23;1-3-20(2)8-10-27(11-9-20)15-12-23-17-16(25-26-18(17)24-15)13-4-6-14(7-5-13)28-19(21)22;1-2-11-7-8-24(10-14(11)25)15-9-20-17-16(22-23-18(17)21-15)12-5-3-4-6-13(12)19/h5-8,11,14H,4,9-10,12-13H2,1-3H3,(H,24,25,26);5-8,13-14H,4,9-12H2,1-3H3,(H,24,25,26);2,5-6,12-13H,3-4,7-11H2,1H3,(H,25,26,27);4-7,12,19H,3,8-11H2,1-2H3,(H,24,25,26);3-6,9,11,14,25H,2,7-8,10H2,1H3,(H,21,22,23)/t;;13-;;11-,14-/m..1.1/s1.
What are the key properties of (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine?
(4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine has a molecular weight of 1894.16 g/mol, XLogP of 22.18, 16 rotatable bonds, 6 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for (4R)-8-[3-(3-chloro-2-fluorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-8-azaspiro[4.5]decane;(3S,4R)-1-[3-(2-chlorophenyl)-2H-pyrazolo[3,4-b]pyrazin-6-yl]-4-ethylpiperidin-3-ol;3-[4-(difluoromethoxy)phenyl]-6-(4-ethyl-4-methylpiperidin-1-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-3-yl)-2H-pyrazolo[3,4-b]pyrazine;6-(4-ethyl-4-methylpiperidin-1-yl)-3-(1-methylindol-4-yl)-2H-pyrazolo[3,4-b]pyrazine is sourced from PubChem (CID 158299598), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).